A Phase II Trial of VInflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer.
Phase of Trial: Phase II
Latest Information Update: 24 Nov 2013
At a glance
- Drugs Vinflunine (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 26 Jul 2010 Actual end date (Nov 2009) added as reported by ClinicalTrials.gov.
- 26 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Oct 2007 Status change from recruiting to in progress.